|
PeproTech
αil-4 (500-p24) αil 4 (500 P24), supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/%CE%B1il-4/pm39401241-68-3-11?v=PeproTech Average 90 stars, based on 1 article reviews
αil-4 (500-p24) - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
αil4 ![]() αil4, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/%CE%B1il-4/pmc04946513-44-34-35?v=Becton+Dickinson Average 90 stars, based on 1 article reviews
αil4 - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Transplantation Direct
Article Title: Kinetics of Alloantigen-Specific Regulatory CD4 T Cell Development and Tissue Distribution After Donor-Specific Transfusion and Costimulatory Blockade
doi: 10.1097/TXD.0000000000000580
Figure Lengend Snippet: Abrogation of linked suppression by co-injection of blocking antibodies. Self-B6 regulation responses were variable, as measured by linked suppression of recall tv-DTH response on day 14. No significant differences in recovery of TT/DT response from linked suppression by self (B6) antigens were observed on day 14 with IL10, TGFβ or IL35 neutralization, although a trend ( P = 0.06, P = 0.09, and P = 0.06, respectively) was observed. However, allo (CBA)-specific linked suppression responses on day 35 were clearly reversed by the IL10, TGFβ or IL35 cytokine-neutralizing antibodies (all P < 0.001). The co-injection of αIL4 antibody did not elicit a significant LS reversal effect relative to IgG isotype control. Data were presented as mean with SEM from 3 to 6 mice in each group (Open symbols, wild type B6 mice; closed symbols, Foxp3/YFP, TdTomRed/Ebi3 reporter B6 mice), and analyzed by Student t test (*** P < 0.001).
Article Snippet: Coinjected blocking antibodies were: αTGFβ (BD Pharmigen) (10 μg), αIL10 (R&D Systems) (10 μg), a combination of αp35 (R&D Systems) + αEbi3 (provided by Dr. Vignali, University of Pittsburgh) (1 μg of each), and
Techniques: Injection, Blocking Assay, Neutralization